Article Versions Notes

Hermenean A, Dossi E, Hamilton A, Trotta MC, Russo M, Lepre CC, Sajtos C, Rusznyák Á, Váradi J, Bácskay I, et al. Chrysin Directing an Enhanced Solubility through the Formation of a Supramolecular Cyclodextrin–Calixarene Drug Delivery System: A Potential Strategy in Antifibrotic Diabetes Therapeutics. Pharmaceuticals. 2024; 17(1):107. https://doi.org/10.3390/ph17010107

Hermenean, Anca, Eleftheria Dossi, Alex Hamilton, Maria Consiglia Trotta, Marina Russo, Caterina Claudia Lepre, Csilla Sajtos, Ágnes Rusznyák, Judit Váradi, Ildikó Bácskay, and et al. 2024. "Chrysin Directing an Enhanced Solubility through the Formation of a Supramolecular Cyclodextrin–Calixarene Drug Delivery System: A Potential Strategy in Antifibrotic Diabetes Therapeutics" Pharmaceuticals 17, no. 1: 107. https://doi.org/10.3390/ph17010107

Hermenean, A., Dossi, E., Hamilton, A., Trotta, M. C., Russo, M., Lepre, C. C., Sajtos, C., Rusznyák, Á., Váradi, J., Bácskay, I., Budai, I., D’Amico, M., & Fenyvesi, F. (2024). Chrysin Directing an Enhanced Solubility through the Formation of a Supramolecular Cyclodextrin–Calixarene Drug Delivery System: A Potential Strategy in Antifibrotic Diabetes Therapeutics. Pharmaceuticals, 17(1), 107. https://doi.org/10.3390/ph17010107